NEWS zu "SHMN" sohm die geht durch die decke

 

 

 

habt sie auf dem radar. sie rennt heute ins ende  

 

 

rennt ins ende.  

 

auf hohem nivou gehalten und nicht weit weg vom tages höchststand. das wird heute noch and die 0,1 gehen. morgen dann eine fette kerze richtung 0,3. schaut euch den 2-3 jahres chart an wo sie her kommt und das vol. heute. das passiert nicht ohne grund.  

SOHM India Targets $600 Million Generic Drug Market for Asthma and Respiratory Disease in India With Addition of 6 New Pharmaceu
SOHM (OTC) (USOTC:SHMN)
Intraday Stock Chart
Today : Thursday 28 October 2010

SOHM, Inc. (PINKSHEETS: SHMN), a generic pharmaceutical manufacturer that produces and markets generic drugs covering all major treatment categories today announced the addition of 6 new generic pharmaceutical products targeting asthma and respiratory disease. India's respiratory drug market size is approximately $600 million annually. Acute respiratory diseases in India have grown by 33 percent from 2005-2010 which is a significantly higher growth rate compared to other communicable diseases.
Respiratory diseases are one of the most common forms of ill-health plaguing the Indian population today. They are also a leading cause of hospitalization and death. Allergic respiratory disorders, in particular asthma, have recorded abnormally high levels in India. Even though genetic predisposition is one of the main factors of respiratory disease there is an increased prevalence due to urbanization, air pollution and environmental tobacco smoke.

"The market for respiratory products in India is huge," stated Shailesh Shah, Vice President for Corporate Strategy at SOHM, Inc. "This market, combined with India being the TB capital of the world, makes the market potential of the additional new generic pharmaceutical products substantial. With total drug spending on respiratory disease in India at approximately $600 million we feel confident this product line will increase revenue as distribution begins this quarter."

About SOHM, Inc.

SOHM, Inc. is a generic pharmaceutical manufacturer that produces and markets generic drugs covering all major treatment categories. Global headquarters is located in North America with manufacturing sites in India. Generic pharmaceuticals are exported globally with a focus on distribution in emerging markets in Africa, Latin America, and Southeast Asia. www.sohm.com

Safe Harbor Statement

This press release contains statements, which may constitute "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of SOHM, Inc., and members of their management as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. Important factors currently known to management that could cause actual results to differ materially from those in forward-statements include fluctuation of operating results, the ability to compete successfully and the ability to complete before-mentioned transactions. The company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results.

For more information, please contact:

SOHM, Inc.  

ht es schnell auf ein neues tages hoch  

 

 

 

 

 

gap trend heute. mit großen stücken hoch und mit kleinen runter. heute geht es weiter richtung sonne. 10 mil. aktien ist ein wahnsinns vol. für diese firma. da kommt die nächsten tage etwas großes. das waren insider. wird spannend  

0,06x0,07 die läuft heute über die 0,1  

ei 65. gestern 60 geschlossen. fett  

geschlossen. festhalten wir fliegen  

SOHM India to Partner With Global Efficiency Firm to Manage Triple Digit Growth Within India, Sri Lanka, Southeast Asia, Africa,

Date : 10/29/2010 @ 8:55AM
Source : MarketWire
Stock : SOHM, Inc. (SHMN)
Quote : 0.06 0.0 (0.00%) @ 8:57AM


SOHM India to Partner With Global Efficiency Firm to Manage Triple Digit Growth Within India, Sri Lanka, Southeast Asia, Africa,
SOHM (OTC) (USOTC:SHMN)
Intraday Stock Chart
Today : Friday 29 October 2010

SOHM, Inc. (PINKSHEETS: SHMN), a generic pharmaceutical manufacturer that produces and markets generic drugs covering all major treatment categories, announced today that the Company is negotiating to partner with a global efficiency firm headquartered in India. The firm will assist with managing soaring growth in India, Sri Lanka, Southeast Asia, Africa, Mexico and Latin America. Areas of concentration include the ideal route and strategies to manage triple digit growth, enhancing product offerings, improving management competencies, and effective management of the global sales force. The firm will also advise on strategic acquisitions which include additional manufacturing facilities and regional opportunities to acquire market share in key pharmaceutical markets.

"Operational enhancements, streamlining manufacturing facilities, and efficiency focused changes are exciting, and all point to the success that we are experiencing as a company," stated Shailesh Shah, Vice President for Corporate Strategy at SOHM, Inc. "SOHM is growing quickly, and we are planning future growth by investing in expertise that is both aggressive and strategic. We believe hiring specialists will improve all aspects of our Company thereby increasing the efficiency and effectiveness of our operations and potentially reducing costs and improving profit margins."

About SOHM, Inc.

SOHM, Inc. is a generic pharmaceutical manufacturer that produces and markets generic drugs covering all major treatment categories. Global headquarters is located in North America with manufacturing sites in India. Generic pharmaceuticals are exported globally with a focus on distribution in emerging markets in Africa, Latin America, and Southeast Asia. www.sohm.com

Safe Harbor Statement

This press release contains statements, which may constitute "forward-looking statements" within the meaning of the Securities Act of 1933 and the Securities Exchange Act of 1934, as amended by the Private Securities Litigation Reform Act of 1995. Those statements include statements regarding the intent, belief or current expectations of SOHM, Inc., and members of their management as well as the assumptions on which such statements are based. Prospective investors are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those contemplated by such forward-looking statements. Important factors currently known to management that could cause actual results to differ materially from those in forward-statements include fluctuation of operating results, the ability to compete successfully and the ability to complete before-mentioned transactions. The company undertakes no obligation to update or revise forward-looking statements to reflect changed assumptions, the statements to reflect changed assumptions, the occurrence of unanticipated events or changes to future operating results.

For more information, please contact:

SOHM, Inc.

Investor Relations

(714) 522-6700